Alexandria Real Estate Equities, Inc.
ARE
|
News
A
|
$119.49
0.78%
0.0%
1.2M
|
Finance
(0.0% 1d) (-6.2% 1m) (-4.4% 1y) (0.0% 2d) (0.0% 3d) (2.5% 7d) (10.37% volume)
Earnings Calendar: 2024-01-29
Market Cap: $ 20,905,167,666
http://www.are.com
Sec Filling | Patents | 439 employees
(US) Alexandria Real Estate Equities, Inc. is an urban office real estate investment trust, which engages in the ownership, operation, development, and redevelopment of life science and technology properties. It also provides a space for lease to the life science and technology industries which are primarily located in AAA urban innovation cluster locations. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.
spac
add to watch list Paper trade email alert is off
Press-releases
Alexandria Real Estate Equities, Inc. Reports: 1Q24 Net Income per Share - Diluted of $0.97; and 1Q24 FFO per Share - Diluted, as Adjusted, of $2.35
Published: 2024-04-22 (Crawled : 20:00) - prnewswire.com
ARE | News A | $119.49 0.78% 0.0% 1.2M
|
Finance
| Email alert
Add to watchlist
Alexandria Real Estate Equities, Inc. Announces Significant Early Renewal and 10-Year Lease Extension With Longstanding Credit Tenant Takeda at the Alexandria Center at Kendall Square Mega Campus in Cambridge
Published: 2024-03-04 (Crawled : 12:00) - prnewswire.com
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.69%
H: 0.35%
C: 0.14%
ARE | News A | $119.49 0.78% 0.0% 1.2M
|
Finance
|
| O: -0.01%
H: 1.98%
C: 1.41%
extension
Alexandria Real Estate Equities, Inc. Announces Long-Term Tenant AstraZeneca Is Investing $300 Million in a Next-Generation Cell Therapy Manufacturing Facility at the Alexandria Center for Life Science - Shady Grove Mega Campus in Rockville, Maryland
Published: 2024-02-12 (Crawled : 13:30) - prnewswire.com
ARE | News A | $119.49 0.78% 0.0% 1.2M
|
Finance
|
| O: 0.59%
H: 1.87%
C: 0.91%
life million astrazeneca cell therapy
Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $400,000,000 of Senior Notes due 2036 $600,000,000 of Senior Notes due 2054
Published: 2024-02-01 (Crawled : 00:00) - prnewswire.com
BNPQF | News | $70.45 -13.4% 1.8K
|
Finance
|
| O: -7.79%
H: 0.0%
C: 0.0%
BNPQY | News | $35.58 -2.68% 97K
|
Finance and Insurance
|
| O: -2.09%
H: 0.33%
C: -0.33%
USB A | $40.97 -0.19% 0.0% 7M
|
Finance
|
| O: -0.76%
H: 1.33%
C: 0.67%
ARE | News A | $119.49 0.78% 0.0% 1.2M
|
Finance
|
| O: -2.27%
H: 1.91%
C: 1.48%
offering
Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2023 Distributions
Published: 2024-01-26 (Crawled : 13:30) - prnewswire.com
ARE | News A | $119.49 0.78% 0.0% 1.2M
|
Finance
|
| O: 0.32%
H: 0.61%
C: 0.44%
year treatment
Alexandria Real Estate Equities, Inc. Celebrates 30 Years at the Vanguard and Heart of the $5 Trillion Secularly Growing Life Science Industry
Published: 2024-01-05 (Crawled : 13:30) - prnewswire.com
ARE | News A | $119.49 0.78% 0.0% 1.2M
|
Finance
|
| O: -1.18%
H: 2.87%
C: 1.87%
life vanguard growing heart
Alexandria Real Estate Equities, Inc. Announces Long-Term 165,940 RSF, Full-Building Lease With Novo Nordisk for R&D Center at the Alexandria Center for Life Science - Waltham Mega Campus in Greater Boston
Published: 2023-12-15 (Crawled : 13:30) - prnewswire.com
ARE | News A | $119.49 0.78% 0.0% 1.2M
|
Finance
|
| O: -1.26%
H: 0.56%
C: -1.97%
life
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.27 per Common Share for 4Q23, an Increase of 3 Cents Over 3Q23, and an Aggregate of $4.96 per Common Share for 2023, an Increase of 24 Cents, or 5 Percent, Over 2022
Published: 2023-12-04 (Crawled : 13:30) - prnewswire.com
ARE | News A | $119.49 0.78% 0.0% 1.2M
|
Finance
|
| O: -0.47%
H: 2.42%
C: 1.96%
Alexandria Real Estate Equities, Inc. Announces Exclusive Partnership With Lilly to Expand Lilly Gateway Labs to San Diego
Published: 2023-11-28 (Crawled : 21:00) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
ARE | News A | $119.49 0.78% 0.0% 1.2M
|
Finance
|
| O: -0.19%
H: 3.05%
C: 2.77%
partnership
Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care
Published: 2023-11-06 (Crawled : 14:30) - biospace.com/
ARE | News A | $119.49 0.78% 0.0% 1.2M
|
Finance
|
| O: -0.31%
H: 0.32%
C: -0.74%
GLPG | News | $29.47 1.38% 1.36% 120K
|
Health Technology
|
| O: 4.99%
H: 0.15%
C: -2.11%
multi-year cell car-t agreement therapy
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
CONN | $3.71 1.37% 1.35% 72K
|
Retail Trade
|
21:30
RELL P 2500 | $10.335 2.13% 2.08% 98K
|
Electronic Technology
|
20:01
TGEN P 6000 | $0.6897 39.71% 2.3K
|
Utilities
|
18:30
CMTV P 700 | $15.74 17.43% 12K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.0% 2.5M
|
Finance
|
17:30
HNVR | $16.76 2.51% 2.45% 3.5K
|
|
16:30
VUZI P 34500 | $1.315 -2.59% -2.66% 690K
|
Electronic Technology
|
16:00
TPL P 3 | $587.81 0.34% -0.39% 41K
|
Miscellaneous
|
15:00
ETST P 79000 | $0.065 -67.14% 110K
|
Manufacturing
|
11:30
MCFT P 26039 | $21.06 -2.05% -2.09% 130K
|
Consumer Durables
|
00:00
YORW P 29 | $35.625 0.58% 0.58% 56K
|
Utilities
|
19:01
BANF P 256 | $92.29 1.11% 1.09% 92K
|
Finance
|
15:30
RMCF | $3.57 0.28% 2.8K
|
Consumer Non-Durables
|
20:10